A new genetics project could help “unlock a series of secrets about devastating diseases”, the NHS says.
Under the scheme, 11 Genomics Medicine Centres are being set up in English hospitals to gather DNA samples to help devise targeted treatments for a wide range of diseases.
It is focusing on cancer and rare genetic diseases.
The aim is to sequence 100,000 genomes within three years in order to develop new tests and drugs.
Doctors will offer suitable patients the opportunity to take part in the scheme.
They will have to agree to have their genetic code and medical records – stripped of anything that could identify them – made available to drugs companies and researchers.
Up to 25,000 cancer patients will have the genetic code of their healthy tissue compared to the genetic code of their tumour.
A giant game of spot-the-difference will then take place to identify the precise mutations in DNA that are causing a patient’s tumour.
This would allow targeted medicines to be developed.
Genetic code
Previous genetics research has shown how different cancers can be – for example that breast cancer is not one disease but at least 10 – each with a different cause and life expectancy and each needing a different treatment.
And the development of targeted drugs such as Herceptin – given only if a patient’s breast tumour has a certain mutation – has been possible because of genetics research.
Meanwhile, 15,000 patients with rare diseases will have their genome compared with those of their parents and grandparents.
Thousands of genetic diseases – which are individually rare but combined affect large numbers of people – could be identified by finding mistakes in the three billion pairs of letters that make up our genetic code.
The resulting knowledge could give patients an explanation for a disease that has plagued their entire life.
Prof Graeme Black, who will lead the project in Manchester, told the BBC: “It’s possible to sequence an individual’s entire genetic make-up, their genome, in merely a few days where five years ago that was completely unimaginable.
Read more: NHS DNA scheme to fight cancer and genetic diseases
The Latest on: Genomics Medicine Centres
[google_news title=”” keyword=”Genomics Medicine Centres” num_posts=”10″ blurb_length=”0″ show_thumb=”left”]
via Google News
The Latest on: Genomics Medicine Centres
- King Faisal Specialist Hospital & Research Centre: KFSH&RC Pushes Boundaries with a Year of Achievements Across Three Centres of Excellenceon May 10, 2024 at 10:10 am
Furthermore, the centre's focus on pediatric oncology boasts a 97% five-year survival rate for renal tumors and a 92% survival rate for acute lymphoblastic leukemia in children. With rapid ...
- KFSH&RC Pushes Boundaries with a Year of Achievements Across Three Centres of Excellenceon May 10, 2024 at 3:57 am
Furthermore, the centre’s focus on pediatric oncology boasts a 97% five-year survival rate for renal tumors and a 92% survival rate for acute lymphoblastic leukemia in children. With rapid ...
- Genomics Game-Changers: 3 Stocks Unlocking the Secrets of Lifeon May 10, 2024 at 3:00 am
InvestorPlace - Stock Market News, Stock Advice & Trading Tips Genomics is the future of medicine. With it, companies are racing to shed ...
- Rwanda initiative: public health boost with cervical cancer screening for 20,000on May 9, 2024 at 4:59 pm
BGI Genomics and the Rwanda Biomedical Centre (RBC) launched a cervical cancer screening program in Ngoma District, Rwanda. Aimed at providing 20,000 HPV DNA tests for local women, the initiative ...
- BGI Group subsidiary moves to boost healthcareon May 8, 2024 at 11:01 pm
The BGI Genomics, a subsidiary of BGI Group, has partnered with the Rwanda Biomedical Centre to launch a cervical cancer screening programme in Ngoma District, Eastern Province, Rwanda.This programme, ...
- UAE: Breast Cancer Prevention, Precision Medicine To Be Advanced By New Partnershipon May 6, 2024 at 12:35 pm
Breast cancer is the most common cancer among women worldwide. According to the Ministry of Health and Prevention (MoHAP), it is the leading cause of cancer death, resulting in 11.6 per cent of all ...
- MGRC and Twistcode Technologies collaborate to develop advanced bioinformatics platformon May 6, 2024 at 4:34 am
Malaysian Genomics Resource Centre Bhd’s (MGRC) wholly-owned subsidiary MGRC Therapeutics Sdn Bhd (MGRCT) has entered a memorandum of understanding (MoU) with Twistcode Technologies Sdn Bhd.
- M42 signs groundbreaking agreement with AstraZenecaon May 6, 2024 at 2:50 am
AstraZeneca signs M42 as its clinical genomics partner of choice in the Middle East region; The partnership will leverage M42’s cutting-edge genomics capabilities to sequence br ...
- Genomics plc and GSK collaborate to harness polygenic risk scores in clinical trialson May 6, 2024 at 1:48 am
Genomics plc and GSK announced a new collaboration to explore the potential for using polygenic risk scores (PRS) in clinical trials, to improve understanding of disease risk and patient selection, ...
- Exhibition Focuses On QPHI Leading Shift Towards Preventive Healthcareon May 1, 2024 at 12:35 am
Doha, Qatar: Qatar Foundation's Qatar Precision Health Institute (QPHI) is leading the shift towards preventive healthcare. It empowers individuals with genomic information to make informed decisions ...
via Bing News